Zizza Associates is categorized under Biologicals and Allied Products in New York City, NY and active since 2008.
Zizza Associates was established in 2008, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Biologicals and Allied Products business, which does work in the BOTH market, and is classified as a Biologicals and Allied Products, under code number 3254140 by the NAICS.
If you are seeking more information, feel free to contact Salvatore Zizza at the company’s single location by writing to 641 Lexington Avenue # 1702, New York City, New York NY 10022 or by phoning (212) 758-7733. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Zizza Associates |
| Contact Person: | Salvatore Zizza |
| Address: | 641 Lexington Avenue # 1702, New York City, New York 10022 |
| Phone Number: | (212) 758-7733 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Biologicals and Allied Products |
| SIC Code: | 5122 |
| NAICS Code: | 3254140 |
| Share This Business: |
Zizza Associates was started in 2008 to provide professional Biologicals and Allied Products under the SIC code 5122 and NAICS code 3254140. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Salvatore Zizza for inquiries that concern Zizza Associates by calling the company number (212) 758-7733, as your correspondence is most welcome. Additionally, the physical location of the single location of Zizza Associates can be found at the coordinates 40.759124,-73.970361 as well as the street address 641 Lexington Avenue # 1702 in New York City, New York 10022.
For its online presence, you may visit Zizza Associates’s website at and engage with its social media outlets through on Twitter and on Facebook.